Therefore, our findings demonstrate functional role of potential oncogeneDOT1L in promoting multistep breast carcinogenesis associated with EMT and stemcell-like phenotype as a novel epigenetic regulator of EMT-TFs, suggesting DOT1L to be apromising target for aggressive breast cancer therapy. This evidence concerns the gene DOT1L and breast cancer.